Biodetection UC Davis and SpectraPass Partner on Rapid Mass Spec COVID-19 Test by Global Biodefense Staff April 26, 2021
Industry News University of Bristol Scientists Form Halo Therapeutics to Develop ‘Pan-Corona’ Antivirals by Global Biodefense Staff April 15, 2021
Industry News OSU’s New Vaccine Candidate for COVID-19 Capitalizes on Measles Vaccine’s Successful History by Global Biodefense Staff March 16, 2021
Industry News DARPA Awards Nucleic Acids On-Demand (NOW) Contract to GE Research and Collaborators by Global Biodefense Staff March 2, 2021
Industry News Thin Film Freezing Shows Efficacy for Biodefense Countermeasures Against Alphaviruses and Filoviruses by Global Biodefense Staff February 19, 2021
Industry News BioFactura Funded $13M Contract Option for Smallpox Biodefense Therapeutic by Global Biodefense Staff February 19, 2021
Biodetection Smiths Detection’s BioFlash Shown to Detect Airborne COVID-19 by Global Biodefense Staff February 18, 2021
Industry News FDA Authorizes Moderna COVID-19 mRNA Vaccine for Emergency Use by Global Biodefense Staff December 19, 2020
Industry News Altimmune Poised to Begin Phase 1 Clinical Trial of Single-Dose Intranasal COVID-19 Vaccine by Global Biodefense Staff November 25, 2020
Health Security Celdara’s Pandemic Security Initiative Introduces Scientific Advisory Board Founding Members by Global Biodefense Staff November 5, 2020
Biodetection InBios Awarded $12.7M to Boost Production of Two COVID-19 Diagnostics by Global Biodefense Staff October 31, 2020
Industry News Regeneron Halts Trial for Antibody Cocktail in Sickest COVID-19 Patients by Global Biodefense Staff October 30, 2020
Industry News Inspirotec Expands Into RFU Innovation and Research Park by Global Biodefense Staff October 21, 2020
Biodetection Centivax Licenses Anti-COVID-19 Antibodies to Thermo Fisher by Global Biodefense Staff October 20, 2020
Biosecurity CRDF Global Selected to Support Biological Threat Reduction Program Contracts by Global Biodefense Staff October 19, 2020
Biodetection MIS-C Detection: BARDA Invests in Rapid Diagnostic for Pediatric Complication of SARS-CoV-2 by Global Biodefense Staff October 15, 2020
Industry News U.S. Invests in Pandemic Vaccine Manufacturing Capacity with $31M Contract to Cytiva by Global Biodefense Staff October 15, 2020
Biodetection DoD Expands U.S. Domestic Diagnostics Capacity with $481M Cue Health Deal by Global Biodefense Staff October 15, 2020
Biodetection BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV by Global Biodefense Staff October 8, 2020
